High-performance experts.

When it’s all on the line.

News

Unanimous Arbitration Panel Awards $25.4 Million in Biogas Facility EPC Dispute 

Tanner Weil provided an expert report and testimony on behalf of Air Liquide, a multinational supplier of industrial gases and related services, in a construction dispute arbitration surrounding the development and construction of an anaerobic digester biogas facility in Pennsylvania. The unanimous arbitration panel awarded more than $25.4 million, an amount determined directly from Mr. Weil’s analysis and testimony.

Read More
Article

Data Center Noise Pollution: An Emerging Risk for Developers, Operators, and Investors 

As demand for artificial intelligence (AI), cloud computing, and digital storage continues to accelerate, data centers have become one of the most critical infrastructure assets in the modern economy. Historically, attention surrounding data center development has focused on power consumption, water usage, carbon emissions, and land use. Increasingly, however, noise pollution is emerging as a significant source of community concern, regulatory scrutiny, and potential litigation.

Read More

Who We Are

Insightful Experts.
Globally Connected.

When the stakes are high, our globally integrated expert teams thrive on working through the most daunting problems in ways that remove uncertainty and instill confidence.

Learn More About Us

Intellectually Curious.
Relentlessly People-Centric.

We are very selective in whom we choose to join our team. Then again, you wouldn’t want it any other way.

Learn About Career Opportunities

Secretariat by the Numbers

700+

Experts and Advisors Around the World

80%

Engaged by the Top 100 Global Law Firms

10,000+

Engagements Completed on 6 Continents

1st

Ranked in GAR 100 Expert Witness Firms’ Power Index 2024, 2025, & 2026

new resource

Artificial Intelligence Insights

Essential insights on how to respond to AI-driven litigation and disputes, develop robust security and governance strategies, and stay informed about emerging AI trends and regulatory developments.

Explore AI Insights

Latest Insights

Article  |  September 10, 2026

Chemicals of Interest in the Food and Beverage Industry: Understanding Risks Beyond Detection  

Food manufacturers, processors, distributors, and retailers continue to face heightened scrutiny regarding the presence of naturally occurring and anthropogenic contaminants in food and beverage products. As contaminant-related litigation and Proposition 65 enforcement continue to expand in the food and beverage industry, companies face increasing pressure to understand the risks associated with contaminants of interest. Effective risk management requires more than simply detecting a constituent of concern. A reported detection is often the beginning of the evaluation, not the conclusion.

Read More
Article  |  September 4, 2026

Artificial Turf Under Scrutiny: Performance, Safety, and Health Risks

Recent project failures and litigation trends have brought increased scrutiny to artificial turf systems, including allegations that they present multi-dimensional risk related to design, construction, product performance, environmental and health exposure, and potential injury.

Read More

See All Insights

featured Engagements

Eric Poer Reflects on a Historic Forensic Investigation That Drove Sweeping Reforms at Wells Fargo in the Wake of Historic Fraud Scandal 

Eric Poer, an internationally-recognized forensic accounting, investigations, and disputes expert, led the forensic accounting and data analytics team retained to support A&O Shearman in conducting an independent investigation into Wells Fargo’s sales practices—an inquiry launched in response to one of the most significant financial consumer fraud scandals in U.S. history.

Read More
View All Engagements
featured Engagements

Biopharmaceutical Reasonable Royalties on Trial

When our client, a biopharmaceutical company, had exclusively licensed a patent for a novel type of cancer immunotherapy, a competitor undertook substantial efforts to be first to market for its lead indication despite being aware of potential infringement claims against its therapy. Upon the competitor achieving FDA approval, our client filed patent infringement claims. After an eight-day trial, the jury returned a verdict in favor of our client with a damages award that precisely matched the trial testimony.

Read More
View All Engagements

Become One of the Experts

Join the team of high-performing experts clients call when they are facing their greatest challenges and opportunities.

Learn More About Our Career Opportunities

Talk to Our Insightful Experts

Reach out today